You are here: Industry Insights > Terns Pharmaceuticals

News List

Pharmaceutical News of the Week | CPhI.CN - Transactions PharmaSources/Caicai
August 06, 2020
Daiichi Sankyo announced on July 27 that it entered into a global cooperation and development agreement with AstraZeneca for Daiichi Sankyo’s DS-1062.
Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial biospectrumasia
June 16, 2019
Trial to evaluate the safety and tolerability of the Farnesoid X Receptor (FXR) agonist TERN-101 to support its clinical trials for the treatment of nonalcoholic steatohepatitis (NASH)
Terns Pharmaceuticals Initiates Phase 1 Clinical Trial of TERN-101 americanpharmaceuticalreview
June 14, 2019
Terns Pharmaceuticals announced the initiation of a Phase 1 clinical trial of TERN-101, a farnesoid X receptor (FXR) agonist, being developed for the treatment of non-alcoholic steatohepatitis (NASH).
Terns Pharmaceuticals Announces the Appointment of Chief Medical Officer americanpharmaceuticalreview
January 21, 2019
Terns Pharmaceuticals announced the appointment of Erin Quirk, M.D. as Chief Medical Officer (CMO). Dr. Quirk brings more than two decades of clinical medicine and drug development experience....